In this study, we describe how the molecular characterization of the translocation breakpoints of a variant t(9;22) in a patient with CML in blast crisis lead to the discovery of involvement of the EVI1 locus. This evidence concerns the gene MECOM and chronic myelogenous leukemia, BCR-ABL1 positive.